PRHSX Holdings — T. Rowe Price Health Sciences Fund, Inc.
All 279 reported holdings of T. Rowe Price Health Sciences Fund, Inc. (PRHSX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 14.28% | $1.71B |
| Johnson & Johnson | 6.63% | $792.01M |
| Unitedhealth Group, Inc. | 5.99% | $715.61M |
| Abbvie, Inc. | 5.10% | $609.30M |
| Merck & Co. Inc. | 4.01% | $478.73M |
| Gilead Sciences, Inc. | 2.82% | $336.99M |
| Thermo Fisher Scientific, Inc. | 2.52% | $301.21M |
| Vertex Pharmaceuticals, Inc. | 2.28% | $272.28M |
| Bristol-Myers Squibb Co. | 2.11% | $251.85M |
| Abbott Laboratories | 1.89% | $225.34M |
| Intuitive Surgical, Inc. | 1.87% | $223.73M |
| Amgen, Inc. | 1.82% | $217.35M |
| Stryker Corp. | 1.78% | $212.88M |
| Elevance Health, Inc. | 1.53% | $182.63M |
| Natera, Inc. | 1.44% | $171.60M |
| Danaher Corp. | 1.43% | $170.25M |
| Guardant Health, Inc. | 1.23% | $146.37M |
| Cardinal Health, Inc. | 1.03% | $123.35M |
| Royalty Pharma PLC- Cl A | 0.97% | $115.61M |
| Cvs Health Corp. | 0.94% | $111.95M |
| Tenet Healthcare Corp. | 0.94% | $111.93M |
| Kymera Therapeutics, Inc. | 0.89% | $106.07M |
| Protagonist Therapeutics, Inc. | 0.85% | $101.56M |
| Moderna Therapeutics, Inc. | 0.83% | $98.94M |
| Brightspring Health Services | 0.82% | $98.28M |
| Revolution Medicines, Inc. | 0.78% | $92.80M |
| Roivant Sciences Ltd. | 0.70% | $83.96M |
| Alnylam Pharmaceuticals, Inc. | 0.67% | $80.19M |
| Viatris, Inc. | 0.66% | $78.56M |
| Charles River Laboratories | 0.62% | $73.99M |
| Argenx SE - ADR | 0.59% | $71.09M |
| Edwards Lifesciences Corp. | 0.59% | $70.59M |
| Centene Corp. | 0.57% | $67.92M |
| Spyre Therapeutics Inc | 0.53% | $63.20M |
| Definium Therapeutics Inc | 0.51% | $60.56M |
| T. Rowe Price Government Reserve Fund | 0.50% | $60.05M |
| Insmed, Inc. | 0.49% | $58.46M |
| Twist Bioscience Corp. | 0.48% | $57.10M |
| Parabilis Medicines, Inc. Lockup Shares PP | 0.47% | $56.05M |
| Chugai Pharmaceutical Co. Ltd. | 0.45% | $54.12M |
| Astrazeneca PLC | 0.44% | $52.95M |
| United Therapeutics Corp. | 0.44% | $52.37M |
| Krystal Biotech, Inc. | 0.43% | $51.61M |
| Boston Scientific Corp. | 0.43% | $51.07M |
| Medtronic PLC | 0.41% | $49.30M |
| Erasca, Inc. | 0.40% | $47.35M |
| Billiontoone, Inc. Cl A | 0.38% | $45.30M |
| Praxis Precision Medicines I | 0.37% | $44.63M |
| Medpace Holdings, Inc. | 0.37% | $44.56M |
| Monte Rosa Therapeutics, Inc. | 0.37% | $44.12M |
| Tango Therapeutics, Inc. | 0.37% | $43.80M |
| Oruka Therapeutics, Inc. | 0.36% | $42.93M |
| Ascendis Pharma A/s | 0.36% | $42.64M |
| Beone Medicines Ltd. | 0.35% | $42.33M |
| Humana, Inc. | 0.35% | $42.22M |
| Dianthus Therapeutics, Inc. | 0.35% | $41.79M |
| Scholar Rock Holding Corp. | 0.34% | $40.60M |
| Kodiak Sciences, Inc. | 0.33% | $39.49M |
| Axsome Therapeutics, Inc. | 0.31% | $37.01M |
| Summit Therapeutics, Inc. | 0.31% | $36.88M |
| Novo-Nordisk A/s-Spons ADR | 0.30% | $36.06M |
| Regeneron Pharmaceuticals | 0.29% | $34.71M |
| Relay Therapeutics, Inc. | 0.29% | $34.44M |
| Ionis Pharmaceuticals, Inc. | 0.29% | $34.41M |
| Cytokinetics, Inc. | 0.28% | $33.69M |
| Vera Therapeutics, Inc. | 0.28% | $33.65M |
| Enliven Therapeutics, Inc. | 0.28% | $32.86M |
| Agilent Technologies, Inc. | 0.27% | $32.52M |
| Mbx Biosciences, Inc. | 0.27% | $32.36M |
| Cg Oncology, Inc. | 0.26% | $31.12M |
| Newamsterdam Pharma Co. NV | 0.26% | $30.92M |
| Waters Corp. | 0.26% | $30.71M |
| Crinetics Pharmaceuticals In | 0.25% | $30.42M |
| Madrigal Pharmaceuticals, Inc. | 0.25% | $30.26M |
| Liquidia Corp. | 0.24% | $29.10M |
| Mirum Pharmaceuticals, Inc. | 0.24% | $28.98M |
| Beam Therapeutics, Inc. | 0.24% | $28.90M |
| Nurix Therapeutics, Inc. | 0.24% | $28.78M |
| West Pharmaceutical Services | 0.23% | $27.72M |
| Ideaya Biosciences, Inc. | 0.23% | $27.09M |
| Bridgebio Pharma, Inc. | 0.23% | $27.05M |
| Teva Pharmaceutical-Sp ADR | 0.23% | $26.92M |
| Rhythm Pharmaceuticals, Inc. | 0.22% | $26.83M |
| Viridian Therapeutics, Inc. | 0.22% | $26.60M |
| Alkermes PLC | 0.22% | $26.40M |
| Treeline Bio Ser A-1 Cvt Pfd Stock Pp | 0.21% | $25.47M |
| Alignment Healthcare, Inc. | 0.21% | $25.38M |
| Generate Biomedicines Inc Lockup Shs PP | 0.21% | $24.84M |
| Vaxcyte, Inc. | 0.21% | $24.75M |
| Rapport Therapeutics, Inc. | 0.20% | $23.83M |
| Aktis Oncology Inc. Lockup Shs PP | 0.20% | $23.36M |
| Immunome, Inc. | 0.19% | $23.16M |
| Structure Therapeutics, Inc. ADR | 0.19% | $22.51M |
| Palvella Therapeutics, Inc. | 0.18% | $22.04M |
| Treeline Bio Ser A Cvt Pfd Stock Pp | 0.18% | $21.99M |
| Climb Bio Inc | 0.18% | $21.33M |
| Icon PLC | 0.17% | $20.88M |
| Immunocore Holdings PLC-ADR | 0.17% | $20.49M |
| Kailera Therapeutics, Inc. | 0.17% | $19.92M |
| Celldex Therapeutics, Inc. | 0.15% | $18.41M |
| Bicara Therapeutics, Inc. | 0.15% | $17.55M |
| Cencora, Inc. | 0.14% | $17.31M |
| Avalyn Pharma Inc Lockup Shares PP | 0.14% | $17.28M |
| Sonova Holding AG-Reg | 0.14% | $17.17M |
| Grs - Security Lending Collateral | 0.14% | $17.12M |
| Cellanome Series A Cvt Pfd Stock Pp | 0.14% | $16.92M |
| Alumis, Inc. | 0.14% | $16.74M |
| Apogee Therapeutics, Inc. | 0.14% | $16.74M |
| Oric Pharmaceuticals, Inc. | 0.14% | $16.60M |
| Insitro Ser B Cvt Pfd Pp | 0.14% | $16.16M |
| Veeva Systems, Inc. Cl A | 0.14% | $16.15M |
| Seaport Therapeutics Inc Lockup Shares PP | 0.13% | $16.06M |
| Moonlake Immunotherapeutics | 0.13% | $15.42M |
| Encompass Health Corp. | 0.13% | $15.30M |
| Genesis Molecular AI Ser B CVT PFD PP | 0.12% | $14.84M |
| Ocular Therapeutix, Inc. | 0.12% | $14.07M |
| Biohaven Ltd. | 0.12% | $14.00M |
| Abivax SA-ADR | 0.12% | $13.87M |
| Cogent Biosciences, Inc. | 0.12% | $13.82M |
| Kailera Therapeutics Inc Lockup Shares PP | 0.12% | $13.81M |
| Shattuck Labs, Inc. | 0.12% | $13.78M |
| Stoke Therapeutics, Inc. | 0.11% | $13.71M |
| Immix Biopharma, Inc. | 0.11% | $13.67M |
| Incyte Corp. | 0.11% | $13.59M |
| Arsenal Biosciences Ser C Cvt Pfd Pp | 0.11% | $13.46M |
| Arrowhead Pharmaceuticals, Inc. | 0.11% | $13.45M |
| Delfi Diagnostics Sr A Cvt Pfd Stock Pp | 0.11% | $13.40M |
| Parabilis Medicines, Inc. | 0.11% | $13.32M |
| Avalyn Pharma, Inc. | 0.11% | $13.04M |
| Immunocore Holdings Cb 2.50% 2/30 | 0.11% | $12.93M |
| Sionna Therapeutics, Inc. | 0.11% | $12.65M |
| Mirum Pharma 6 month Lockup Shs PP | 0.10% | $12.50M |
| Mirum Pharma 9 month Lockup Shs PP | 0.10% | $12.50M |
| Belite Bio, Inc. - ADR | 0.10% | $12.39M |
| Endeavor Bio Series B Cvt Pfd Stock Pp | 0.10% | $12.19M |
| Clear Labs Series C Cvt Pfd Pp | 0.10% | $12.12M |
| Biontech SE-ADR | 0.10% | $11.78M |
| Insitro Ser C Cvt Pfd Pp | 0.09% | $10.76M |
| Aktis Oncology, Inc. | 0.09% | $10.76M |
| Galvanize Thera Ser C-2 NV Cvt Pfd Pp | 0.09% | $10.70M |
| Cullinan Therapeutics Inc | 0.09% | $10.63M |
| Quest Diagnostics, Inc. | 0.09% | $10.62M |
| Kartos Therapeutics Sr C Cvt Pfd Stk Pp | 0.09% | $10.59M |
| National Resilience Sr B Cvt Pfd Stk Pp | 0.09% | $10.41M |
| Cleerly Ser C Cvt Pfd Stk Pp | 0.09% | $10.28M |
| Denali Therapeutics, Inc. | 0.09% | $10.24M |
| Kardium Inc Ser D-6 CVT Pfd Stock PP | 0.09% | $10.19M |
| Third Arc Bio Ser A Cvt Pfd Pp | 0.08% | $10.12M |
| Tarsus Pharmaceuticals, Inc. | 0.08% | $9.95M |
| Pharvaris NV | 0.08% | $9.75M |
| Tyra Biosciences, Inc. | 0.08% | $9.70M |
| Disc Medicine, Inc. | 0.08% | $9.68M |
| Element Biosciences Ser C Cvt Pfd Stock Pp | 0.08% | $9.51M |
| Corvus Pharmaceuticals, Inc. | 0.08% | $9.21M |
| Avalo Therapeutics, Inc. | 0.07% | $8.72M |
| Nanobiotix | 0.07% | $8.44M |
| Iqvia Holdings, Inc. | 0.07% | $8.11M |
| Kardium Inc Series D-7 CVT PFD Stock PP | 0.07% | $7.80M |
| Nchroma Bio Ser I Cvt Pfd Stock Pp | 0.06% | $7.68M |
| Kyverna Therapeutics, Inc. | 0.06% | $7.63M |
| Atrium Therapeutics, Inc. | 0.06% | $7.62M |
| Hemab Therapeutics Holdings | 0.06% | $7.60M |
| Olema Pharmaceuticals, Inc. | 0.06% | $7.30M |
| Delfi Diagnostics Sr B Cvt Pfd Stock Pp | 0.06% | $7.25M |
| Kardium, Inc. Ser D-5 Cvt Pfd Stock Pp | 0.06% | $7.25M |
| Allogene Therapeutics, Inc. | 0.06% | $7.16M |
| Obsidian Therapeutic Sr C Cvt Pfd Stk Pp | 0.06% | $7.06M |
| Wave Life Sciences Ltd. | 0.06% | $6.90M |
| Seaport Therapeutics, Inc. | 0.05% | $6.50M |
| Tenax Therapeutics, Inc. | 0.05% | $6.49M |
| Adaptive Biotechnologies | 0.05% | $6.28M |
| Scribe Thera Ser B Cvt Pfd Stock Pp | 0.05% | $6.22M |
| Genesis Molecular AI Ser A CVT PFD PP | 0.05% | $6.19M |
| Alto Neuroscience, Inc. | 0.05% | $6.02M |
| Iovance Biotherapeutics, Inc. | 0.05% | $5.99M |
| National Resilience Sr C Cvt Pfd Stk Pp | 0.05% | $5.67M |
| Cabaletta Bio, Inc. | 0.05% | $5.58M |
| Procept Biorobotics Corp. | 0.05% | $5.56M |
| Spyglass Pharma, Inc. | 0.05% | $5.50M |
| Xencor, Inc. | 0.05% | $5.48M |
| Galvanize Therapeutics Ser C CVT PFD PP | 0.05% | $5.44M |
| Generate Biomedicines, Inc. | 0.04% | $5.31M |
| Celcuity, Inc. | 0.04% | $5.16M |
| Color Health Sr D Cvt Pfd Stock Pp | 0.04% | $5.08M |
| Color Health Sr D-1 Cvt Pfd Stock Pp | 0.04% | $5.02M |
| Eikon Therapeutics, Inc Lockup Shs PP | 0.04% | $4.85M |
| Evommune, Inc. | 0.04% | $4.61M |
| Eikon Therapeutics, Inc. | 0.04% | $4.56M |
| Freenome Holdings Ser B Cvt Pfd Pp | 0.04% | $4.51M |
| Inspire Medical Systems, Inc. | 0.04% | $4.41M |
| Kardium Inc Series D-8 CVT PFD Stock PP | 0.04% | $4.39M |
| Deepsight Tech Inc SER C CVT PFD PP | 0.04% | $4.38M |
| SPAC PCSC Freenome PIPE COMMIT PP | 0.04% | $4.29M |
| Manus Bio, Inc. Series One-6 Cvt Pfd Pp | 0.03% | $3.99M |
| Sensorion SA | 0.03% | $3.71M |
| Odyssey Therapeutics Inc Lockup Shares PP | 0.03% | $3.56M |
| Xenon Pharmaceuticals, Inc. | 0.03% | $3.50M |
| Tessera Therapeutics Ser C' Cvt Pfd Pp | 0.03% | $3.49M |
| Agios Pharmaceuticals, Inc. | 0.03% | $3.48M |
| Odyssey Therapeutics, Inc. | 0.03% | $3.42M |
| Crescent Biopharma, Inc. | 0.03% | $3.38M |
| Biomarin Pharmaceutical | 0.03% | $3.36M |
| Immatics NV | 0.03% | $3.26M |
| Endeavor Bio Ser C Cvt Pfd Pp | 0.03% | $3.20M |
| Galvanize Thera Ser C-1 Cvt Pfd Pp | 0.03% | $3.17M |
| Ge Healthcare Technologies, Inc. | 0.03% | $2.99M |
| Kartos Therapeutics SR D CVT PFD STK PP | 0.02% | $2.90M |
| Mirum Pharma Indemnity Holdback Shs PP | 0.02% | $2.79M |
| Treeline Bio SER A-2 CVT PFD PP | 0.02% | $2.78M |
| Freenome Holdings Ser C Cvt Pfd Pp | 0.02% | $2.69M |
| Bicycle Therapeutics PLC-ADR | 0.02% | $2.66M |
| Dyne Therapeutics, Inc. | 0.02% | $2.60M |
| Element Biosciences Ser D Cvt Pfd Pp | 0.02% | $2.51M |
| Element Biosciences Ser D-1 Cvt Pfd Pp | 0.02% | $2.51M |
| Arbor Bio Series B Cvt Pfd Stock Pp | 0.02% | $2.41M |
| Pax Labs Class A Common Pp | 0.02% | $2.27M |
| Entrada Therapeutics, Inc. | 0.02% | $2.18M |
| Lumicks Tech Ser D Cvt Pfd Stock Pp | 0.02% | $2.17M |
| Tessera Therapeutics Ser D Cvt Pfd Pp | 0.02% | $1.98M |
| Immuneering Corp. - Class A | 0.02% | $1.93M |
| Revolution Medicines, Inc. Wts 12/26 | 0.02% | $1.87M |
| Dna Script Series C Cvt Pfd Stock Pp | 0.02% | $1.81M |
| Caris Life Sciences, Inc. | 0.01% | $1.77M |
| Delfi Diagnostics CVT Prom Note PP | 0.01% | $1.73M |
| Color Health Series E Cvt Pfd Stock Pp | 0.01% | $1.71M |
| BridgeBio Oncology Therapeutics Inc | 0.01% | $1.70M |
| Freenome Holdings Ser D Cvt Pfd Pp | 0.01% | $1.52M |
| Maplight Therapeutics, Inc. | 0.01% | $1.52M |
| Arbor Bio Series C Cvt Pfd Stock Pp | 0.01% | $1.46M |
| Verily Health, Inc. CL B Common Stock PP | 0.01% | $1.27M |
| Saluda Medical Inc Lockup Shs CDI PP | 0.01% | $1.18M |
| Clear Labs Ser D Cvt Pfd Stock Pp | 0.01% | $1.18M |
| Mirum Pharma Escrow Indemnity PP | 0.01% | $1.13M |
| Tectonic Therapeutic, Inc. | 0.01% | $1.05M |
| Cabaletta Bio Common WTS 09/26 PP | 0.01% | $1.03M |
| Honor Technology Ser D Cvt Pfd Pp | 0.01% | $939.28K |
| Capsule Corp. Series E Cvt Pfd Stock Pp | 0.01% | $915.72K |
| Capsule Corp. Series 1-D Cvt Pfd Stock | 0.01% | $861.75K |
| Sail Biomedicines Ser B Cvt Pfd Stock Pp | 0.01% | $760.43K |
| Kartos Therapeutics CVT Prom Note 03/27 PP | 0.01% | $741.02K |
| Aura Biosciences, Inc. | 0.01% | $696.82K |
| Profoundbio Escrow Fund Payment Pp | 0.01% | $669.26K |
| Reflexion Med CVT Note issued 081325 PP | 0.01% | $651.98K |
| Reflexion Med CVT Note issued 072525 PP | 0.01% | $656.77K |
| Reflexion Med CVT Note issued 082725 PP | 0.01% | $647.18K |
| Honor Technology Ser E Cvt Pfd Stock Pp | 0.01% | $628.74K |
| Freenome Holdings Ser F Cvt Pfd Pp | 0.00% | $517.45K |
| Treeline Bio Common WTS 8/35 PP | 0.00% | $416.83K |
| Kartos Therapeutics CVT Note 05/27 PP | 0.00% | $185.25K |
| PROGNOMIQ INC CL A Common PP | 0.00% | $91.00K |
| Mirum Pharma Escrow Expense Fund PP | 0.00% | $45.69K |
| Chromacode INC SER AA CVT PFD STK PP | 0.00% | $44.58K |
| Mirum Pharma Escrow Working Capital PP | 0.00% | $45.69K |
| Affinivax Expense Fund Pp | 0.00% | $11.56K |
| Gyroscope Therapeutics Mlstne Pymt 3 Pp | 0.00% | $0 |
| Reflexion Medical, Inc. Cvt Pfd Sr E-X Pp | 0.00% | $2.60K |
| Reflexion Medical Ser F Cvt Pfd Stock Pp | 0.00% | $1.79K |
| Ring Therapeutics, Inc. Pp | 0.00% | $0 |
| Reflexion Medical, Inc. Cvt Pfd Sr C-X Pp | 0.00% | $3.26K |
| Reflexion Medical, Inc. Cvt Pfd Sr D-X Pp | 0.00% | $1.46K |
| Saluda Med Common WTS 3/26 PP | 0.00% | $0 |
| Chromacode, Inc. Pp | 0.00% | $757 |
| Somalogic, Inc. Wts 8/26 | 0.00% | $0 |
| Profoundbio Expense Fund Payment Pp | 0.00% | $117 |
| Mirum Pharma Milestone $750 mil PP | 0.00% | $0 |
| Blue Marlin Therapeutics Common Stock PP | 0.00% | $180 |
| Mirum Pharma Milestone $500 mil PP | 0.00% | $0 |
| Medici Tx Platform $3 mil Milestone PP | 0.00% | $0 |
| Exact Sciences Fda Milestone Pp | 0.00% | $0 |
| Exact Sciences Cmo Milestone Pp | 0.00% | $0 |
| Genedx Holdings Corp. Wts 7/26 | 0.00% | $600 |
| Generation Bio Co. | 0.00% | $0 |
| Gyroscope Therapeutics Mlstne Pymt 1 Pp | 0.00% | $0 |
| Gyroscope Therapeutics Mlstne Pymt 2 Pp | 0.00% | $0 |
| Affinivax Next Gen Prod Mileston Evnt Pp | 0.00% | $0 |
| Affinivax Afx3772 Milestone Event Pp | 0.00% | $0 |
| Ginkgo Bioworks Hlds Ern Out Shs 600 Pp | 0.00% | $0 |
| Ginkgo Bioworks Hlds Ern Out Shs 700 Pp | 0.00% | $0 |
| Ginkgo Bioworks Hlds Ern Out Sh 800 Pp | 0.00% | $0 |
PRHSX overview: performance, fees, allocation and SEC filings